XML 122 R102.htm IDEA: XBRL DOCUMENT v3.24.3
Segment reporting - results of operations of reportable segments (Details) - USD ($)
$ in Millions
12 Months Ended
Aug. 31, 2024
Aug. 31, 2023
Aug. 31, 2022
Segment Reporting Information, Operating Income (Loss) [Abstract]      
Sales $ 147,658 $ 139,081 $ 132,703
Adjusted operating income: 2,624 3,871 5,133
Depreciation and amortization 2,459 2,257 1,990
Capital expenditures: 1,381 2,117 1,734
Impairment of goodwill, intangibles and long-lived assets (13,422) (299) (783)
Acquisition-related amortization (1,075) (1,126) (855)
Transformational cost management (891) (1,181) (763)
Acquisition-related costs (542) (323) (223)
Certain legal and regulatory accruals and settlements (561) (7,466) (768)
Adjustments to equity earnings in Cencora (162) (211) (218)
LIFO provision (47) (187) (135)
Store damage and inventory loss insurance recovery 0 40 0
Operating (loss) income (14,076) (6,882) 1,387
Reportable Segments | U.S. Retail Pharmacy      
Segment Reporting Information, Operating Income (Loss) [Abstract]      
Sales 115,778 110,314 109,078
Adjusted operating income: 2,167 3,689 5,029
Depreciation and amortization 1,422 1,362 1,415
Capital expenditures: (1,041) 1,421 (1,207)
Reportable Segments | U.S. Retail Pharmacy | Pharmacy      
Segment Reporting Information, Operating Income (Loss) [Abstract]      
Sales 88,867 82,118 80,434
Reportable Segments | U.S. Retail Pharmacy | Retail      
Segment Reporting Information, Operating Income (Loss) [Abstract]      
Sales 26,911 28,195 28,643
Reportable Segments | International      
Segment Reporting Information, Operating Income (Loss) [Abstract]      
Sales 23,552 22,198 21,830
Adjusted operating income: 793 935 726
Depreciation and amortization 370 328 355
Capital expenditures: (247) 308 (295)
Reportable Segments | International | Pharmacy      
Segment Reporting Information, Operating Income (Loss) [Abstract]      
Sales 3,598 3,664 3,727
Reportable Segments | International | Retail      
Segment Reporting Information, Operating Income (Loss) [Abstract]      
Sales 7,887 7,324 6,924
Reportable Segments | International | Wholesale      
Segment Reporting Information, Operating Income (Loss) [Abstract]      
Sales 12,067 11,211 11,178
Reportable Segments | U.S. Healthcare      
Segment Reporting Information, Operating Income (Loss) [Abstract]      
Sales 8,345 6,570 1,795
Adjusted operating income: (134) (566) (370)
Depreciation and amortization 651 560 211
Capital expenditures: 91 375 218
Corporate and Other      
Segment Reporting Information, Operating Income (Loss) [Abstract]      
Sales (16) 0 0
Adjusted operating income: (202) (187) (251)
Depreciation and amortization 16 8 9
Capital expenditures: $ 2 $ 13 $ 15